PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Chart, page-3166

  1. 400 Posts.
    lightbulb Created with Sketch. 23
    S
    slura, unfortunately I could not agree more with you. I did exactly what you have suggested.
    The retail offer would have me entitled to circa 8799 shares.
    I wanted to over subscribe to a level more than 4 times that number. I was worried that I would miss that full investment so I purchase on market below 1.30 and purchased my investment as per my personal investment thesis. Which was, as I said 4 times my retail allocations.
    It will be interesting to see the retail take up. And it’s a pity it stayed sub 1.30 for much of the time since the cap raise decision.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.